Total Funding
53
66
Total FundingSeries C raised
Growth Score 53 in past quarter
-4 pts
Heat Score 66 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
172456
Anbiping focuses on R&D, production, and service of pathological diagnostic products.
Acquired by 
Sichuan Jinyu Automobile City Group
- Xiangting Cai: Chairman & General Manager & Founder
About the Company
Anbiping is a number of reagents and supporting devices have indeed been independently created by Anbiping, which focuses on tumour screening and correct diagnosis. Pathology is the main application department. It has been established that product lines for liquid-based cytology, polymerase chain reaction, immunohistochemistry, and fluorescence in
situ hybridization can be used to screen for and diagnose tumors based on everything from cell morphology to protein expression.
